Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pancreatic Neoplasms, Neoplasm Metastasis or Liver Metastases
and you are
between 18 and 90
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this study is to demonstrate the feasibility of an aggressive multimodal approach among patients with stage IV pancreatic cancer (PAC) with isolated, low-volume hepatic metastasis (LVHM). We will evaluate and describe the surgical and overall outcomes of an initial cohort of subjects who undergo pancreatectomy and hepatic resection/ablation for PAC with LVHM. The end of study results will be reviewed by the Hepatiobiliary Multidisciplinary Conference (HDMC) and Surgery Audit Committee (SAC) to determine the appropriateness of adding this treatment arm for patients with oligometastatic metastatic pancreatic cancer.

Provided treatments

  • Procedure: Hepatic Resection or Ablation with Pancreaticoduodenectomy
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02892305. The sponsor of the trial is Duke University and it is looking for 15 volunteers for the current phase.
Official trial title:
Hepatic Resection for Metastatic Pancreatic Cancer